News

Novo Nordisk launches Wegovy in India, expanding GLP-1 obesity drug market. The product competes with Eli Lilly's Mounjaro ...
Deepseek AI’s scare kicked off the year, rattling faith in the “Magnificent Seven” and the broader tech space. 💵💰Don't miss ...
Boots Online Doctor has revealed the 'very common' side-effects of Mounjaro you need to know about after thousands of people ...
Ahead of the launch, the firm has taken steps to amplify its production capacities to ensure adequate supply, and believes ...
From weight-loss clinics to wellness spas and online, knockoff GLP-1s are everywhere and being heavily promoted as the answer ...
In a time of both misinformation and too much information, quality journalism is more crucial than ever. By subscribing, you ...
THEY are arguably the biggest medical breakthrough of recent times. And from this week, so-called ‘fat jabs’ will be made ...
Danish drugmaker Novo Nordisk has launched its popular weight-loss drug Wegovy in India, months after its rival Mounjaro’s ...
The growing popularity of weight loss jabs could be affecting shopping habits in UK supermarkets, a leading research group ...
Mounjaro has been approved for both type 2 diabetes and weight loss; however, access will be limited by strict eligibility ...
A Drug box of Ozempic containing Semaglutide for treatment of type 2 diabetes and long-term weight management on a table and ...
Prescriptions for tirzepatide injections will not be available from GP surgeries or pharmacies in East and North Yorkshire – ...